Professor Andrew Briggs

BSc (Hons) MSc DPhil


15-17 Tavistock Place
United Kingdom

Professor of Health Economics at the London School of Hygiene & Tropical Medicine, I  previously held the William R Lindsay Chair in Health Economics at the University of Glasgow. Following a sabbatical at Memorial Sloan Kettering Cancer Center, New York in 2016/17, I remain a Visiting Investigator, collaborating with Dr Peter Bach on value frameworks for oncology medications.

I have  co-authored two textbooks, one published by OUP entitled Decision Modelling for Health Economic Evaluation, and another published by Wiley entitled Statistical Methods for Cost-Effectiveness Analysis.

A link to my GooGle Scholar page:


Department of Health Services Research and Policy
Faculty of Public Health and Policy


Centre for Evaluation
Centre for Statistical Methodology


My main methodological focus of research has been health economic evaluation, particularly statistical methods for cost-effectiveness analysis.  This includes statistical methods for estimation of parameters for cost-effectiveness models as well as statistical analysis of cost-effectiveness alongside clinical trials.  I have a more general interest in epidemiological methods, in particular the use of prognostic scoring methods for predicting health outcomes and the relationship with heterogeneity in cost-effectiveness analysis.

Research Area
Decision analysis
Economic evaluation
Randomised controlled trials
Health economics
United Kingdom
United States of America
South Africa
European Union
North America
Sub-Saharan Africa (all income levels)

Selected Publications

Health related quality of life utility weights for economic evaluation through different stages of chronic kidney disease: a systematic literature review.
Cooper JT; Lloyd A; Sanchez JJG; Sörstadius E; Briggs A; McFarlane P
Health and quality of life outcomes
Novel risk stratification algorithm for estimating the risk of death in patients with relapsed multiple myeloma: external validation in a retrospective chart review.
Hájek R; Gonzalez-McQuire S; Szabo Z; Delforge M; DeCosta L; Raab MS; Bouwmeester W; Campioni M; Briggs A
BMJ open
Evaluation of Pathologic Complete Response as a Surrogate for Long-Term Survival Outcomes in Triple-Negative Breast Cancer.
Huang M; O'Shaughnessy J; Zhao J; Haiderali A; Cortes J; Ramsey S; Briggs A; Karantza V; Aktan G; Qi CZ
Journal of the National Comprehensive Cancer Network : JNCCN
Association of Pathologic Complete Response with Long-Term Survival Outcomes in Triple-Negative Breast Cancer: A Meta-Analysis.
Huang M; O'Shaughnessy J; Zhao J; Haiderali A; Cortés J; Ramsey SD; Briggs A; Hu P; Karantza V; Aktan G
Cancer research
How methodological frameworks are being developed: evidence from a scoping review.
McMeekin N; Wu O; Germeni E; Briggs A
BMC medical research methodology
Economic evaluation of culprit lesion only PCI vs. immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock: the CULPRIT-SHOCK trial.
Robles-Zurita JA; Briggs A; Rana D; Quayyum Z; Oldroyd KG; Zeymer U; Desch S; de Waha-Thiele S; Thiele H
The European journal of health economics : HEPAC : health economics in prevention and care
Earlier diagnosis of lung cancer in a randomised trial of an autoantibody blood test followed by imaging.
Sullivan FM; Mair FS; Anderson W; Armory P; Briggs A; Chew C; Dorward A; Haughney J; Hogarth F; Kendrick D
The European respiratory journal
See more Publications